SILO PHARMA, INC. Notes Payable, Noncurrent
SILO PHARMA, INC. (SILO) had Notes Payable, Noncurrent of $1.06 thousand as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Notes and Loans, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2022-03-28
- 2021-03-31: Notes Payable, Noncurrent $1.06K.
- 2020-12-31: Notes Payable, Noncurrent $4.25K.
- 2012-12-31: Notes Payable, Noncurrent $15.00K.
- 2012-09-30: Notes Payable, Noncurrent $15.00K.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2021-03-31 | $1.06K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $4.25K 10-K · filed 2022-03-28 |
| 2012-12-31 | $15.00K 10-Q · filed 2013-11-14 |
| 2012-09-30 | $15.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $15.00K 10-Q · filed 2012-08-01 |
| 2012-03-31 | $15.00K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $0.00 10-Q · filed 2012-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |